GGrantIndex
Sort

53,477 grants matching addiction

INTERVAL TIMING IN MOUSE MODELS OF PARKINSONISM

$424,787
Mona Buhusi · Utah State University · R15 · FY2014 · NS

MIDARP at CCNY

$424,711
Eitan Friedman · City College Of New York · R24 · FY2009 · DA

Dopamine D2 Receptors in Primate Models of Cocaine Abuse

$424,689
Michael A Nader · Wake Forest University Health Sciences · R01 · FY2008 · DA

Neurotrophic and ontogenic factors in medial orbitofrontal cortical function

$424,673
Shannon Leigh Gourley · Emory University · R01 · FY2023 · DA

FOLLOW-UP OF THE MULTIMODAL TREATMENT STUDY OF CHILDREN WITH ATTENTION DEFICIT H

$424,602
Karen Wells · Duke University · N01 · FY2011 · DA

Regulation of Dopamine Transporter by Trafficking

$424,572
Alexander D Sorkin · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DA

GROUP CBT FOR DEPRESSION AND AOD DISORDERS

$424,560
Katherine E Watkins · Rand Corporation · R01 · FY2008 · DA

A National Survey on Naloxone Use and Access

$424,545
David Powell · Rand Corporation · R21 · FY2024 · DA

Studies on the the mechanism of OPRM1 biased agonism and in vivo consequences: Di

$424,517
Ping-Yee Law · University Of Minnesota · R01 · FY2012 · DA

EHR Phenotyping and Genomics of Opioid Addiction (Project 1)

$424,504
Vanessa Troiani · Research Triangle Institute · P50 · FY2024 · DA

Role of Extended Amygdala in Opiate and Cocaine Abuse

$424,447
Gary S. Aston-Jones · Medical University Of South Carolina · R37 · FY2007 · DA

Gender Differences in a Follow-up of Opiate Users in Ca

$424,380
Christine E Grella · University Of California Los Angeles · R01 · FY2007 · DA

Varenicline and Smoking Cessation in Schizophrenia

$424,378
S. Hossein Fatemi · University Of Minnesota · R01 · FY2010 · DA

Regulation of Dopamine Transporter by Trafficking

$424,373
Alexander D Sorkin · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DA

Nutritional Effects On Essential Fatty Acid Composition

$424,266
Joseph Hibbeln · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA

Connectome-based prediction and neurodevelopmental trajectories of alcohol phenotypes across development

$424,262
Sarah Yip · Yale University · R01 · FY2022 · AA

Relationship Dynamics and Young Adult Drug Use and Abuse

$424,259
Thomas J Dishion · Arizona State University-Tempe Campus · R01 · FY2013 · AA

Research Project 2: Can Family-Centered Prevention Programming Reduce Neuroimmune Vulnerabilities for Drug Use and Health Risk among African American Adolescents?: A Randomized Prevention Trial

$424,252
Gene H Brody · University Of Georgia · P50 · FY2023 · DA

Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV.

$424,251
Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2025 · DA

Prison Interventions and HIV Prevention Collaboration

$424,221
Frederick Lewis Altice · Yale University · R01 · FY2011 · DA

The Effects of State and Federal Insurance Policies on Quality of Care for Autism

$424,128
Douglas L. Leslie · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2014 · MH

The Sex-specific Roles and Neural Processing Correlates of Future Outcome Estimation in the Drug Addiction Process

$424,126
Clinton D Kilts · Univ Of Arkansas For Med Scis · R01 · FY2019 · DA

Project 3: Methods for tobacco exposure reduction in humans

$424,120
Dorothy K Hatsukami · University Of Minnesota · P50 · FY2007 · DA

Competing roles of microRNAs and RNA-binding proteins in drug addiction

$424,105
Nora Irma Perrone-Bizzozero · University Of New Mexico Health Scis Ctr · R01 · FY2012 · DA

Development of Orexin-1 Receptor Antagonists to Prevent Drug Relapse

$424,095
Paul J Kenny · Scripps Research Institute, The · R01 · FY2008 · DA